AAAAAA

   
Results: 1-12 |
Results: 12

Authors: KOEHLER M STGEORGE K EHRLICH GD MIRRO J NEUDORF SM RINALDO C
Citation: M. Koehler et al., PREVENTION OF CMV DISEASE IN ALLOGENEIC BMT RECIPIENTS BY CYTOMEGALOVIRUS ANTIGENEMIA-GUIDED PREEMPTIVE GANCICLOVIR THERAPY, Journal of pediatric hematology/oncology, 19(1), 1997, pp. 43-47

Authors: STGEORGE K RINALDO CR
Citation: K. Stgeorge et Cr. Rinaldo, COMPARISON OF COMMERCIALLY AVAILABLE ANTIBODY REAGENTS FOR THE CYTOMEGALOVIRUS PP65 ANTIGENEMIA ASSAY, Clinical and diagnostic virology, 7(3), 1997, pp. 147-152

Authors: KOEHLER M STGEORGE K RINALDO C
Citation: M. Koehler et al., CMV ANTIGENEMIA IN PATIENTS RECEIVING PERIPHERAL STEM-CELL TRANSPLANTS, Bone marrow transplantation, 20(9), 1997, pp. 809-809

Authors: MICHAELS MG ALCENDOR DJ STGEORGE K RINALDO CR EHRLICH GD BECICH MJ HAYWARD GS
Citation: Mg. Michaels et al., DISTINGUISHING BABOON CYTOMEGALOVIRUS FROM HUMAN CYTOMEGALOVIRUS - IMPORTANCE FOR XENOTRANSPLANTATION, The Journal of infectious diseases, 176(6), 1997, pp. 1476-1483

Authors: KUSNE S MANEZ R FRYE BL STGEORGE K ABUELMAGD K TABASCOMENGUILLON J FUNG JJ TODO S RINALDO C EHRLICH GD
Citation: S. Kusne et al., USE OF DNA AMPLIFICATION FOR DIAGNOSIS OF CYTOMEGALOVIRUS ENTERITIS AFTER INTESTINAL TRANSPLANTATION, Gastroenterology, 112(4), 1997, pp. 1121-1128

Authors: STGEORGE K RINALDO CR
Citation: K. Stgeorge et Cr. Rinaldo, EFFECTS OF ENHANCING AGENTS ON DETECTION OF CYTOMEGALOVIRUS IN CLINICAL SPECIMENS (VOL 32, PG 2025, 1994), Journal of clinical microbiology, 34(10), 1996, pp. 2642-2642

Authors: GROSSI P KUSNE S RINALDO C STGEORGE K MAGNONE M RAKELA J FUNG J STARZL TE
Citation: P. Grossi et al., GUIDANCE OF GANCICLOVIR THERAPY WITH PP65 ANTIGENEMIA IN CYTOMEGALOVIRUS-FREE RECIPIENTS OF LIVERS FROM SEROPOSITIVE DONORS, Transplantation, 61(11), 1996, pp. 1659-1660

Authors: MANEZ R KUSNE S RINALDO C AGUADO JM STGEORGE K GROSSI P FRYE B FUNG JJ EHRLICH GD
Citation: R. Manez et al., TIME TO DETECTION OF CYTOMEGALOVIRUS (CMV) DNA IN BLOOD LEUKOCYTES ISA PREDICTOR FOR THE DEVELOPMENT OF CMV DISEASE IN CMV-SERONEGATIVE RECIPIENTS OF ALLOGRAFTS FROM CMV-SEROPOSITIVE DONORS FOLLOWING LIVER-TRANSPLANTATION, The Journal of infectious diseases, 173(5), 1996, pp. 1072-1076

Authors: STGEORGE K RINALDO CR
Citation: K. Stgeorge et Cr. Rinaldo, COMPARISON OF MONOCLONAL-ANTIBODIES FOR IMMUNOSTAINING IN THE CYTOMEGALOVIRUS SHELL VIAL ASSAY ON 4,388 SPECIMENS, Journal of medical virology, 47(3), 1995, pp. 269-271

Authors: KOEHLER M STGEORGE K RINALDO C
Citation: M. Koehler et al., THE EVALUATION OF RESULTS OF CMV ANTIGENEMIA ASSAYS IN BONE-MARROW TRANSPLANT RECIPIENTS, British Journal of Haematology, 89(2), 1995, pp. 427-427

Authors: STGEORGE K RINALDO CR
Citation: K. Stgeorge et Cr. Rinaldo, EFFECTS OF ENHANCING AGENTS ON DETECTION OF CYTOMEGALOVIRUS IN CLINICAL SPECIMENS, Journal of clinical microbiology, 32(8), 1994, pp. 2024-2027

Authors: MANEZ R STGEORGE K LINDEN P MARTIN M KUSNE S GROSSI P HO M RINALDO C
Citation: R. Manez et al., DIAGNOSIS OF CYTOMEGALOVIRUS INFECTIONS BY SHELL VIAL ASSAY AND CONVENTIONAL CELL-CULTURE DURING ANTIVIRAL PROPHYLAXIS, Journal of clinical microbiology, 32(11), 1994, pp. 2655-2659
Risultati: 1-12 |